ONCE-DAILY INHALED UMECLIDINIUM/VILANTEROL COMBINATION THERAPY COMPARED WITH PLACEBO ON EXACERBATIONS IN CHINESE PATIENTS WITH COPD

被引：0
|
作者：
Zheng, Jinping [1 ]
Goh, Aik [2 ]
Huang, Chunchen [2 ]
Luo, Xian [2 ]
机构：
[1] Guangzhou Med Univ, Affiliated Hosp 1, Natl Clin Res Ctr Resp Dis, State Key Lab Resp Dis, Guangzhou, Guangdong, Peoples R China
[2] GlaxoSmithKline, Shanghai, Peoples R China
来源：
RESPIROLOGY | 2017年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
AO110
引用
收藏
页码：48 / 49
页数：2
相关论文
共 50 条
  • [21] A randomised, phase III trial of once-daily fluticasone furoate/vilanterol 100/25 μg versus once-daily vilanterol 25 μg to evaluate the contribution on lung function of fluticasone furoate in the combination in patients with COPD
    Siler, Thomas M.
    Nagai, Atsushi
    Scott-Wilson, Catherine A.
    Midwinter, Dawn A.
    Crim, Courtney
    RESPIRATORY MEDICINE, 2017, 123 : 8 - 17
  • [22] A 24-Week Randomized, Double-Blind, Placebo-Controlled Study Of The Efficacy And Safety Of Once-Daily Umeclidinium/vilanterol 125/25 Mcg In COPD
    Celli, B. R.
    Crater, G.
    Kilbride, S.
    Mehta, R.
    Tabberer, M.
    Kalberg, C. J.
    Church, A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187
  • [23] Real-World Data on the Efficacy of the once-daily Triple Fix Combination of Fluticasone Furoate/Umeclidinium/Vilanterol in the Treatment of Patients with symptomatic COPD: The ELLITHE non-interventional Study
    Beeh, K.
    Scheithe, K.
    Schmutzler, H.
    Krueger, S.
    PNEUMOLOGIE, 2024, 78 : S60 - S60
  • [24] Comparative Assessment Of Umeclidinium/vilanterol (umec/vi) Combination Therapy Among Symptomatic Patients With COPD
    Huisman, E.
    Ismaila, A.
    Naya, I.
    Karabis, A.
    Punekar, Y. S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [25] Comparative assessment of umeclidinium/vilanterol (UMEC/VI) combination therapy among symptomatic COPD patients
    Huisman, Eline
    Cockle, Sarah
    Punekar, Yogesh
    EUROPEAN RESPIRATORY JOURNAL, 2014, 44
  • [26] COST EFFECTIVENESS OF UMECLIDINIUM/VILANTEROL (UMEC/VI) COMBINATION THERAPY AMONG SYMPTOMATIC COPD PATIENTS
    Punekar, Y. S.
    Roberts, G.
    Ismaila, A.
    O'Leary, M.
    VALUE IN HEALTH, 2014, 17 (07) : A595 - A595
  • [27] Comparative Efficacy of Once-Daily Umeclidinium/Vilanterol and Tiotropium/Olodaterol Therapy in Symptomatic Chronic Obstructive Pulmonary Disease: A Randomized Study
    Feldman, Gregory J.
    Sousa, Ana R.
    Lipson, David A.
    Tombs, Lee
    Barnes, Neil
    Riley, John H.
    Patel, Sadhana
    Naya, Ian
    Compton, Chris
    Alcazar Navarrete, Bernardino
    ADVANCES IN THERAPY, 2017, 34 (11) : 2518 - 2533
  • [28] Comparative Efficacy of Once-Daily Umeclidinium/Vilanterol and Tiotropium/Olodaterol Therapy in Symptomatic Chronic Obstructive Pulmonary Disease: A Randomized Study
    Gregory J. Feldman
    Ana R. Sousa
    David A. Lipson
    Lee Tombs
    Neil Barnes
    John H. Riley
    Sadhana Patel
    Ian Naya
    Chris Compton
    Bernardino Alcázar Navarrete
    Advances in Therapy, 2017, 34 : 2518 - 2533
  • [29] EFFECT OF AGE ON EFFICACY AND SAFETY OF ONCE-DAILY SINGLE-INHALER TRIPLE THERAPY FLUTICASONE FUROATE/UMECLIDINIUM/VILANTEROL IN PATIENTS WITH COPD: A POST-HOC ANALYSIS OF THE IMPACT TRIAL
    Hanania, Nicola
    Mannino, David
    Criner, Gerard
    Dransfield, Mark
    Han, Meilan
    Jones, Christine Elaine
    Kilbride, Sally
    Lomas, David
    Martinez, Fernando
    Singh, Dave
    Wise, Robert
    Halpin, David
    Soule, Tedi
    Lima, Robson
    Lipson, David
    CHEST, 2019, 156 (04) : 1750A - 1754A
  • [30] Effect of Age on the Efficacy and Safety of Once-Daily Single-Inhaler Triple-Therapy Fluticasone Furoate/Umeclidinium/Vilanterol in Patients With COPD A Post Hoc Analysis of the Informing the Pathway of COPD Treatment Trial
    Hanania, Nicola A.
    Mannino, David M.
    Criner, Gerard J.
    Dransfield, Mark T.
    Han, MeiLan K.
    Jones, C. Elaine
    Kilbride, Sally
    Lomas, David A.
    Martin, Neil
    Martinez, Fernando J.
    Singh, Dave
    Wise, Robert A.
    Halpin, David M. G.
    Lima, Robson
    Lipson, David A.
    CHEST, 2021, 159 (03) : 985 - 995
12345